Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation

Annals of Neurology

Volumn 43, Issue 5, 1998, Pages 627-633

  Padovan, Claudio S ^a   Yousry, Tarek A ^a   Schleuning, Michael ^a   Holler, Ernst ^a   Kolb, Hans Jochem ^a   Straube, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN ATROPHY; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR;

ADULT; BONE MARROW TRANSPLANTATION; BRAIN DISEASES; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031977266     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430511     Document Type: Article

References (39)

1. Bortin MM, Horowitz MM, Rimm AA. Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey. Ann Intern Med 1992;116:505-512
2. Duell T, van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997;126:184-192
3. Beatty PG. Results of allogeneic bone marrow transplantation with unrelated or mismatched donors. Semin Oncol 1992;19: 13-19
4. Thomas ED. Bone marrow transplantation: past experiences and future prospects. Semin Oncol 1992;19:3-6
5. Herzig RH. The role of autologous bone marrow transplantation in the treatment of solid tumors. Semin Oncol 1992;19: 7-12
6. Davis DG, Patchell RA. Neurologic complications of bone marrow transplantation. Neurol Clin 1988;6:377-387
7. Reece DE, Frei Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991;8:393-401
8. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36:688-703
9. Patchell RA, White CL, Clark AW, et al. Neurologic complications of bone marrow transplantation. Neurology 1985;35: 300-306
10. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 1994;44:681-684
11. Gallardo D, Ferra C, Berlanga JJ, et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;18:1135-1139
12. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996;46: 1004-1009
13. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018-2024
14. Zaudig M, Mittelhammer J, Hiller W, et al. SIDAM: a structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 1991;21: 225-236
15. Yousry TA, Filippi M, Becker C, et al. Comparison of SE, FSE, fast-FLAIR and TGSE sequences in the detection of multiple sclerosis lesions. AJNR 1997;18:959-963
16. Altmann DG. Practical statistics for medical research. London: Chapman and Hall, 1991:268-269
17. STATISTICA for Windows (computer program manual). Tulsa: StatSoft Inc, 1996
18. Mohrmann RL, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990;21:630-639
19. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984;16:569-576
20. Diener HC, Ehninger G, Schmidt H, et al. Neurologische Komplikationen nach Knochenmarkstransplantation. Nervenarzt 1991;62:221-225
21. Andrykowski MA, Schmitt FA, Gregg ME, et al. Neuropsychologic impairment in adult bone marrow transplant candidates. J Clin Oncol 1992;70:2288-2297
22. Meyers CA, Weitzner M, Byrne K, et al. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 1994;12:820-826
23. Andrykowski MA, Altmaier EM, Barnett RL, et al. Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant 1990;6:269-276
24. Baloh RW, Vinters HV. White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch Neurol 1995;52:975-981
25. Ehsan T, Hasan S, Powers JM, Heiserman JE. Serial magnetic resonance imaging in isolated angiitis of the central nervous system. Neurology 1995;45:1462-1465
26. Golden MP, Hammer SM, Wanke CA, Albrecht MA. Cytomegalovirus vasculitis: case reports and review of the literature. Medicine (Baltimore) 1994;73:246-255
27. Caplan LR. Binswanger's disease - revisited. Neurology 1995; 45:626-633
28. Skehan S, Norris S, Hegarty J, et al. Brain MRI changes in chronic liver disease. Eur Radiol 1997;7:905-909
29. Anders KH, Becker PS, Holden JK, et al. Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases. Hum Pathol 1993;24:897-904
30. Kelly P, Staunton H, Lawler M, et al. Multifocal remitting-relapsing cerebral demyelination twenty years following allogeneic bone marrow transplantation. J Neuropathol Exp Neurol 1996;55:992-998
31. Macdonald DR. Neurologic complications of chemotherapy. Neurol Clin 1991;9:955-967
32. Thompson CB, Sanders JE, Flournoy N, et al. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow. Blood 1986;67:195-199
33. Pace MT, Slovis TL, Kelly JK, Abella SD. Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 1995;25: 180-183
34. Wijdicks EF, Wiesner RH, Krom RA. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 1995;45:1962-1964
35. Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol Clin 1988;6:389-403
36. Hickey WF, Kimura H. Graft-vs-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci USA 1987;84:2082-2086
37. Hoogerbrugge PM, Suzuki K, Poorthuis BJ, et al. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 1988;239:1035-1038
38. Unger ER, Sung JH, Manivel JC, et al. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 1993;52:460-470
39. Rouah E, Gruber R, Shearer W, et al. Graft-versus-host disease in the central nervous system: a real entity? Am J Clin Pathol 1988;89:543-546